| 24 May 2026 |
Adamax |
5.6 |
10mg |
9.7mg |
-2.9% |
98.63% |
Lab F |
| 24 May 2026 |
BAM15 |
7.1 |
10mg |
9.9mg |
-1.2% |
99.47% |
Lab G |
| 24 May 2026 |
Retatrutide |
10.0 |
36mg |
(no batch claim) |
37.3mg |
+3.6% |
3G361125 |
| 24 May 2026 |
Hyaluronic acid |
10.0 |
30mg |
28.5mg |
-5.1% |
99.55% |
Lab B |
| 24 May 2026 |
EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 |
7.0 |
5g |
4.8g |
-3.1% |
98.57% |
Lab G |
| 24 May 2026 |
Retatrutide 30mg Pen Kit |
7.2 |
30mg |
32.7mg |
+9.1% |
98.39% |
Lab D |
| 24 May 2026 |
Retatrutide |
7.6 |
10mg |
(no batch claim) |
11.5mg |
+15.0% |
3G101125 |
| 24 May 2026 |
Pinealon |
8.7 |
15mg |
16.2mg |
+8.0% |
96.33% |
Lab G |
| 24 May 2026 |
Oxytocin Acetate |
7.7 |
20mg |
22.3mg |
+11.3% |
99.79% |
Lab D |
| 23 May 2026 |
TB-500 FRAG |
7.8 |
5mg |
4.8mg |
-3.7% |
99.82% |
Lab A |
| 23 May 2026 |
Telmisartan |
9.1 |
50mg |
58.7mg |
+17.3% |
99.93% |
Lab C |
| 21 May 2026 |
Cerebrolysin |
9.2 |
2mg |
2.3mg |
+14.7% |
97.28% |
Lab C |
| 21 May 2026 |
Test Base (No Ester) |
9.1 |
100mg/ml |
104.4mg/ml |
+4.4% |
97.00% |
Lab B |
| 21 May 2026 |
CJC-1295 With DAC |
9.6 |
50mg |
50.6mg |
+1.3% |
95.44% |
Lab D |
| 21 May 2026 |
Halotestin (Fluoxymesterone) |
7.6 |
20mg |
24.0mg |
+19.9% |
97.87% |
Lab G |
| 20 May 2026 |
Retatrutide |
7.0 |
10mg |
11.3mgwebsite |
9.9mg |
-12.2% |
3G101125 |
| 20 May 2026 |
Tirzepatide |
9.0 |
10mg |
11.4mgpackage |
11.4mg |
+0.3% |
2ZG101125 |
| 20 May 2026 |
Dianabol |
6.2 |
100mg |
89.0mg |
-11.0% |
99.96% |
Lab E |
| 20 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
8.3 |
15mg |
16.5mg |
+10.3% |
95.12% |
Lab F |
| 20 May 2026 |
Super Shred |
10.0 |
300mg/ml |
335.9mg/ml |
+12.0% |
96.48% |
Lab F |
| 17 May 2026 |
PTD-DBM |
6.6 |
10mg |
9.5mg |
-5.3% |
97.71% |
Lab F |
| 29 Jan 2026 |
SNAP-8 |
8.0 |
2mg |
1.9mg |
-5.2% |
96.39% |
Lab G |
| 9 Jan 2026 |
GHRP-2 Acetate |
10.0 |
30mg |
28.5mg |
-5.2% |
97.79% |
Lab A |
| 6 Jan 2026 |
(2-Chloroethyl)benzene CAS 622-24-2 |
9.6 |
10g |
9.8g |
-1.7% |
95.32% |
Lab B |
| 29 Dec 2025 |
Enclomiphene |
8.8 |
25mg |
28.0mg |
+12.1% |
97.36% |
Lab C |
| 29 Dec 2025 |
EPO |
10.0 |
10mg |
10.9mg |
+8.7% |
98.63% |
Lab B |
| 12 Dec 2025 |
ACE-031 |
7.9 |
5mg |
5.1mg |
+1.8% |
98.18% |
Lab B |
| 12 Dec 2025 |
Anastrozole (Arimidex) Raw |
6.7 |
100g |
87.3g |
-12.7% |
96.18% |
Lab A |
| 5 Dec 2025 |
Test Enanthate |
7.5 |
300mg/ml |
306.7mg/ml |
+2.2% |
96.66% |
Lab F |
| 24 Nov 2025 |
Tirzepatide |
9.2 |
10mg |
11.6mglabel |
11.05mg |
-5.0% |
2GTZ1019625 |
| 23 Nov 2025 |
Glutathione |
4.5 |
50mg |
51.5mg |
+3.1% |
99.68% |
Lab B |
| 23 Nov 2025 |
Vilon |
10.0 |
15mg |
17.7mg |
+18.1% |
98.68% |
Lab B |
| 17 Nov 2025 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
7.1 |
20mg |
19.3mg |
-3.3% |
95.64% |
Lab A |
| 5 Nov 2025 |
KissPeptin-10 |
9.9 |
30mg |
35.1mg |
+17.1% |
97.29% |
Lab C |
| 5 Nov 2025 |
KPV Oral |
8.9 |
25mg |
21.3mg |
-14.6% |
95.47% |
Lab C |
| 4 Nov 2025 |
Stanozolol (Winstrol) Raw |
7.8 |
100g |
105.1g |
+5.1% |
95.78% |
Lab E |
| 9 Oct 2025 |
IGF-1 LR3 |
9.2 |
5mg |
4.6mg |
-7.6% |
97.20% |
Lab C |
| 3 Oct 2025 |
1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 |
8.4 |
10g |
11.6g |
+16.3% |
96.17% |
Lab B |
| 3 Oct 2025 |
Adipotide |
9.3 |
50mg |
43.7mg |
-12.6% |
97.88% |
Lab B |
| 3 Oct 2025 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
5.0 |
5mg |
5.3mg |
+5.8% |
99.61% |
Lab C |
| 3 Oct 2025 |
Prostamax |
9.8 |
20mg |
24.7mg |
+23.5% |
99.58% |
Lab F |